It could be about an error you missed, a question you should have asked or an unexpectedly positive outcome to a interaction you will never forget — some patients teach a valuable lesson that endures for an entire professional career.
The Pharmaceutical Journal is now accepting entries for its 2019 writing competition, and we want you to write about the experiences that have shaped you as a pharmacist in 500 words or fewer. It can be a poem, a short lyrical piece or a story, and the best entries will be published in The Pharmaceutical Journal.
The winner will receive an Amazon Fire 8 tablet, and there will be a special prize for the best entry from a preregistration trainee/pharmacy student.
Good luck — we very much look forward to reading all your entries.
Competition rules
- The competition is open to all pharmacists, preregistration trainees and pharmacy students.
- Entries must be emailed to our opinion editor, Abigail James, at: abigail.james@rpharms.com by 28 June 2019. Entries should be no longer than 500 words, and include your name, job title, where you work and a portrait photograph.
- All submissions must contain original material and must not have been previously published or accepted for publication prior to submission. Promotion of other companies or websites is not allowed.
- Please evidence any figures and provide suitable references for any important facts in the article, where appropriate.
- The editorial team at The Pharmaceutical Journal have the final say on the winners of this competition and by sending your entry to us, you are granting permission for us to publish and use the content as we see fit. Competition entries cannot be revised once submitted.
- Unfortunately, we are unable to accept entries from employees of the Royal Pharmaceutical Society.
- All authors will be asked to ensure that patient details are changed to ensure confidentiality.
**PLEASE NOTE: DEADLINE NOW EXTENDED TO 12 JULY 2019**
You may also be interested in
The importance of diverse clinical imagery within health education
Government should consider ways to prevent ‘inappropriate overseas prescribing’ of hormone drugs, review recommends
